• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit

    5/27/21 4:07:00 PM ET
    $DEH
    Business Services
    Finance
    Get the next $DEH alert in real time by email

    WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021.

    (PRNewsfoto/Vicarious Surgical)

    Presentation Details

    Title:     Surgical Robotics: The Next 5 Years

    Date:    June 4, 2021

    Time:    7:00 – 9:00 p.m. CT

    About Vicarious Surgical

    Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company's novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company's technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA.*

    The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla's Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures, and Philip Liang's E15 VC. The Company is headquartered in Waltham, MA. 

    Investor Inquiries:

    Mike Piccinino, CFA

    [email protected]

    Press and Media Inquiries:

    Sean Leous

    [email protected] 

    Phone + 1 646 866 4012

    * As of the date of this press release, Vicarious Surgical is not aware of any surgical robotics company that has announced receiving Breakthrough Designation for a full robotics system.

    Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/vicarious-surgical-ceo-adam-sachs-to-present-at-surgical-disruptive-technology-summit-301301287.html

    SOURCE Vicarious Surgical

    Get the next $DEH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $DEH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by D8 Holdings Corp.

      SC 13G - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:27:18 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:25:24 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/28/21 5:02:17 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Khosla Ventures V, L.P. bought $3,333,340 worth of shares (333,334 units at $10.00) (Amendment)

      4/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:49:35 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3: New insider Khosla Ventures Seed C, L.P. claimed ownership of 20,622,788 shares (Amendment)

      3/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:47:08 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3 filed by new insider Patnaik Shrikant

      3 - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/1/21 8:14:50 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    SEC Filings

    See more
    • D8 Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Vicarious Surgical Inc. (0001812173) (Filer)

      10/20/21 4:10:10 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form S-1 filed by D8 Holdings Corp.

      S-1 - Vicarious Surgical Inc. (0001812173) (Filer)

      10/15/21 4:09:48 PM ET
      $DEH
      Business Services
      Finance
    • D8 Holdings Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)

      8-K/A - Vicarious Surgical Inc. (0001812173) (Filer)

      9/23/21 4:07:29 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as "RBOT"

      Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220 million in gross cash proceeds to catalyze advancement of Vicarious Surgical's robotic technology, clinical programs, and strategic business initiatives Combined company to trade on NYSE under ticker symbol "RBOT" Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that the shareholders of D8 Holdings Corp. ("D8") (NYSE:DEH, DEH, DEH WS))), have approved the previously announced bus

      9/15/21 4:50:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical Inc. and D8 Holdings Corp. Announce Additional PIPE Commitments

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE:DEH), a special purpose acquisition company, today announced that they have secured $27 million in additional commitments for a private placement of common stock ("PIPE") in support of their business combination transaction, bringing the aggregate amount of PIPE commitments to $142 million, and the total anticipated gross proceeds of the business combination to approximately $487 million (assuming no redemptions). The additional commitments ensure that

      9/9/21 8:34:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit

      WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021. Presentation Details Title:     Surgical Robotics: The Next 5 YearsD

      5/27/21 4:07:00 PM ET
      $DEH
      Business Services
      Finance